FDA Alignment to Advance ProstACT Global Phase 3 Trial
Go back to FDA Alignment to Advance ProstACT Global Phase 3 Trial| TRANS-LUX CORPORATION (NASDAQ: TLX) | Delayed: 11.33 +0.12 (1.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.21 | 52 Week High | $2.18 | |||
| Open | $11.30 | 52 Week Low | $0.30 | |||
| Day High | $11.39 | P/E | N/A | |||
| Day Low | $11.30 | EPS | $-3.32 | |||
| Volume | 38,809 | |||||
| TRANS-LUX CORPORATION (NASDAQ: TLX) | Delayed: 11.33 +0.12 (1.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.21 | 52 Week High | $2.18 | |||
| Open | $11.30 | 52 Week Low | $0.30 | |||
| Day High | $11.39 | P/E | N/A | |||
| Day Low | $11.30 | EPS | $-3.32 | |||
| Volume | 38,809 | |||||



